Grant Number:	5R21CA268197-02 Interpret this number
Primary Investigator:	Besaratinia, Ahmad
Organization:	University Of Southern California
Project Title:	Development of Biomarkers of Exposure and Effects for Electronic Cigarette Vs. Combustible Cigarette Use
Fiscal Year:	2022

While the reduced levels of toxicants and carcinogens in electronic cigarette (e-cig) vapor may imply lower health risk, it cannot, however, equate to no risk. In fact, exposure to many of the same constituents of e-cig vapor, at various concentrations, has been associated with a variety of respiratory-, cardiovascular-, and immune-related (inflammatory) diseases, and cancer. To date, the long-term health consequences of vaping are largely unknown. Rationale: The biological effects of many harmful chemicals present in both e-cig vapor and cigarette smoke are ascribed to their ability to induce genetic/epigenetic changes that cause transcriptional deregulation of disease-related genes. Approach: We will perform a multi-omics analysis to detect genetic/epigenetic alterations associated with transcriptional deregulation of key functional genes in oral cells and blood leukocytes of healthy adult vapers and smokers in comparison to controls (nonsmokers non-vapers) (N=45/group, matched for age, sex, and race). Aim 1: Applying RNA-sequencing and gene ontology analysis, “we will first screen for deregulation of disease-related genes in oral- and blood cells of vapers and smokers as compared to controls”. Having identified the deregulated genes in each group, we will then employ targeted next-generation sequencing “to detect genetic changes in Aim 2, and epigenetic modifications in Aim 3 within the deregulated genes”. Integration analysis of data from Aims 2 and 3 will identify loci with detectable genetic/epigenetic changes that differentiate, with the highest sensitivity and specificity, vapers and smokers from controls and from one another. Detectable genetic/epigenetic changes associated with aberrant expression of disease-related genes in cells from vapers vs. smokers can serve as novel biomarkers of exposure and effects for vaping vs. smoking. These biomarkers will help inform the health risks or potential benefits of e-cig use vs. smoking. As a secondary goal, we will perform computational modeling “to find correlations between the identified biomarkers and subjects’ tobacco product use frequency and patterns and product characteristics”. This will inform the impact of vaping/smoking dose and product characteristics, including e-cig device features (e.g., model & power) and e- liquid content (nicotine and flavor), and cigarette brand, type, and chemical constituents (e.g., tar), on the biological effects of e-cig use vs. cigarette smoking. Responsiveness to RFA: This proposal will maximize the use of existing biospecimens from our recently completed NIDCR-funded project whose study subjects were recruited through collaboration with USC-TCORS, which is sponsored by the FDA-CTP. This is a unique collection of biospecimens from a representative population in California. No publicly available repository in the US offers similar specimens required for this project. The specimens are currently stored in the PI’s laboratory, and readily available for use. Impact: The findings of this project may generalize to the broader population of vapers and smokers in the US and across the world, thus being of immediate use for the scientific community and regulatory authorities, and of great relevance to the public’s health.




The Untapped Biomarker Potential of MicroRNAs for Health Risk-Benefit Analysis of Vaping vs. Smoking.
Authors: Besaratinia A. , Tommasi S. .
Source: Cells, 2024-08-10 00:00:00.0; 13(16), .
EPub date: 2024-08-10 00:00:00.0.
PMID: 39195220
Related Citations

Exploring the Utility of Long Non-Coding RNAs for Assessing the Health Consequences of Vaping.
Authors: Besaratinia A. , Blumenfeld H. , Tommasi S. .
Source: International Journal Of Molecular Sciences, 2024-08-05 00:00:00.0; 25(15), .
EPub date: 2024-08-05 00:00:00.0.
PMID: 39126120
Related Citations

The State of Research and Weight of Evidence on the Epigenetic Effects of Bisphenol A.
Authors: Besaratinia A. .
Source: International Journal Of Molecular Sciences, 2023-04-27 00:00:00.0; 24(9), .
EPub date: 2023-04-27 00:00:00.0.
PMID: 37175656
Related Citations

Vaping Dose, Device Type, and E-Liquid Flavor are Determinants of DNA Damage in Electronic Cigarette Users.
Authors: Tommasi S. , Blumenfeld H. , Besaratinia A. .
Source: Nicotine & Tobacco Research : Official Journal Of The Society For Research On Nicotine And Tobacco, 2023-02-14 00:00:00.0; , .
EPub date: 2023-02-14 00:00:00.0.
PMID: 36780924
Related Citations

Secondhand smoke affects reproductive functions by altering the mouse testis transcriptome, and leads to select intron retention in Pde1a.
Authors: Tommasi S. , Kitapci T.H. , Blumenfeld H. , Besaratinia A. .
Source: Environment International, 2022 Mar; 161, p. 107086.
EPub date: 2022-01-18 00:00:00.0.
PMID: 35063792
Related Citations

DNA Hydroxymethylation in Smoking-Associated Cancers.
Authors: Besaratinia A. , Caceres A. , Tommasi S. .
Source: International Journal Of Molecular Sciences, 2022-02-28 00:00:00.0; 23(5), .
EPub date: 2022-02-28 00:00:00.0.
PMID: 35269796
Related Citations

A novel role for vaping in mitochondrial gene dysregulation and inflammation fundamental to disease development.
Authors: Tommasi S. , Pabustan N. , Li M. , Chen Y. , Siegmund K.D. , Besaratinia A. .
Source: Scientific Reports, 2021-11-23 00:00:00.0; 11(1), p. 22773.
EPub date: 2021-11-23 00:00:00.0.
PMID: 34815430
Related Citations

Hydroxychloroquine induces oxidative DNA damage and mutation in mammalian cells.
Authors: Besaratinia A. , Caliri A.W. , Tommasi S. .
Source: Dna Repair, 2021 10; 106, p. 103180.
EPub date: 2021-07-16 00:00:00.0.
PMID: 34298488
Related Citations